85.29
BATS BZX Real-Time Price
As of 1:15pm ET
 -0.85 / -0.99%
Today’s Change
59.50
Today|||52-Week Range
89.25
+18.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$40.7B

Company Description

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. Its products are complemented by diagnostic products, genetic tests, bio devices and services.These are designed to meet the needs of veterinarians and the livestock farmers and companion animal.The firm provides its services though five categories namely, anti-infectives, vaccines, parasiticides, medicated feed additives, and other pharmaceuticals. The company was founded in July 2012 and is headquartered in New York, NY.

Contact Information

Zoetis, Inc.
10 Sylvan Way
New Jersey New Jersey 07054
P:(973) 822-7000
Investor Relations:

Employees

Shareholders

Other institutional48.32%
Mutual fund holders44.84%
Individual stakeholders26.52%

Top Executives

Juan Ramón AlaixChief Executive Officer & Director
Kristin C. PeckExecutive Vice President & President-US Operations
Glenn C. DavidChief Financial Officer & Executive Vice President
Catherine Ann KnuppExecutive VP, President-Research & Development
Andrew FentonChief Information Officer & Executive VP